IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer

Clinical trial NCT05827796 · RECRUITING

Trial details

NCT number: NCT05827796
Sponsor: InxMed (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2022-12-08
Primary completion: 2025-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.